Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioage Labs Inc (BIOA)

Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bioage Labs Inc 5885 Hollis St Suite 370 Emeryville CA 94608 USA

https://bioagelabs.com Employees: 64 P: 510-806-1445

Sector:

Medical

Description:

BioAge Labs Inc. is a clinical-stage biopharmaceutical company. It involved in developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of aging. BioAge Labs Inc. is based in RICHMOND, Calif.

Key Statistics

Overview:

Market Capitalization, $K 504,838
Enterprise Value, $K 158,988
Shares Outstanding, K 35,855
Annual Sales, $ 0 K
Annual Net Income, $ -71,110 K
Last Quarter Sales, $ 2,050 K
Last Quarter Net Income, $ -20,170 K
EBIT, $ -89,720 K
EBITDA, $ -89,550 K
60-Month Beta 1.74
% of Insider Shareholders 20.82%
Float, K 28,390
% Float 79.18%
Short Interest 503
Short Float 1.40%
Short Volume Ratio 0.42

Growth:

1-Year Return 131.58%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.56 on 11/06/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -1.52
EPS Growth vs. Prev Qtr 6.67%
EPS Growth vs. Prev Year 91.64%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BIOA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -25.09%
Return-on-Assets % -22.81%
Profit Margin % 0.00%
Debt/Equity 0.01
Price/Sales 85.41
Price/Cash Flow N/A
Price/Book 1.75
Book Value/Share 7.74
Interest Coverage -29.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar